Editorial: frequency of surveillance and survival in hepatocellular carcinoma-authors' reply

被引：0
|
作者：
Kim, H. Y. [1 ]
Lee, J. -H. [2 ,3 ]
机构：
[1] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 48卷 / 02期
关键词：
D O I：
10.1111/apt.14827
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [1] Editorial: redrawing the boundaries for surgical intervention in hepatocellular carcinoma-authors' reply
    Wang, Yan-Yan
    Zhong, Jian-Hong
    Mao, Yi-Lei
    Li, Le-Qun
    Xing, Bao-Cai
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (05) : 616 - 617
  • [2] Editorial: frequency of surveillance and survival in hepatocellular carcinoma
    Senussi, N. H.
    Kowdley, K. V.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 228 - 229
  • [3] Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma-authors' reply
    Menon, Krishna V.
    Hakeem, Abdul R.
    Heaton, Nigel D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1331 - 1332
  • [4] Editorial: The use of Baveno VI and VII criteria for portal hypertension and varices in patients with hepatocellular carcinoma-Authors' reply
    Allaire, Manon
    Thabut, Dominique
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (04) : 480 - 481
  • [5] Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' reply
    Kirstein, Martha M.
    Scheiner, Bernhard
    Pinter, Matthias
    Vogel, Arndt
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 917 - 918
  • [6] Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century - authors' reply
    Simmons, O.
    Fetzer, D. T.
    Yokoo, T.
    Marrero, J. A.
    Yopp, A.
    Parikh, N.
    Browning, T.
    Singal, A. G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 562 - 563
  • [7] Letter: association between proton pump inhibitors and the risk of hepatocellular carcinoma-authors' reply
    Shao, Yu-Hsuan Joni
    Wu, Szu-Yuan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1165 - 1166
  • [8] Comment on Stereotactic Body Radiation Therapy for Small Primary or Recurrent Hepatocellular Carcinoma-Authors' Reply
    Su, Ting-Shi
    Liang, Ping
    Lu, Huan-Zhen
    Liang, Jian
    Gao, Ying-Chuan
    Zhou, Ying
    Huang, Yong
    Tang, Min-Yang
    Liang, Jian-Ning
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (08) : 1032 - 1032
  • [9] Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply
    Bettinger, D.
    Knueppel, E.
    Euringer, W.
    Spangenberg, H. C.
    Roessle, M.
    Thimme, R.
    Schultheiss, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 231 - 231
  • [10] Commentary: predicting survival in hepatocellular carcinoma patients - authors' reply
    Crooks, C.
    Card, T.
    West, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (07) : 681 - 682
12345